Randomized controlled trial: Moxibustion and acupuncture for the treatment of Crohn’s disease

Table 6 Changes in Crohn’s disease activity index scores according to subgroup (baseline to post treatment) (n = 85) (mean ± SD)

Subgroup (treatment group/control group)	Treatment group	Control group	P value1
Sex
Male (27/25)	-118.84 ± 47.29	-48.97 ± 51.95	0.001
Female (16/17)	-109.48 ± 67.45	-16.14 ± 30.12	0.001
CDAI at baseline
CDAI ≤ 220 (24/30)	-110.18 ± 49.51	-26.87 ± 43.11	0.001
CDAI > 220 (19/12)	-121.89 ± 62.10	-57.70 ± 50.59	0.005
Treatment with corticosteroids
Yes (11/13)	-131.30 ± 34.25	-28.86 ± 32.35	0.001
No (32/29)	-109.87 ± 60.05	-38.73 ± 52.36	0.001
Location
L1-Ileal (6/8)	-96.77 ± 55.42	-19.70 ± 51.42	0.020
L2-Colonic (8/11)	-114.31 ± 34.93	-50.29 ± 46.47	0.005
L3-Ileocolonic (29/23)	-119.49 ± 60.00	-34.25 ± 45.56	0.001

¹P values from comparisons between treatment and control groups. CDAI: Crohn’s disease activity index.